MAKALELER

Public Conferences

“Rational Use of Medicines”. Health Conference.…

Devamı
Academic Activities

6th Congress of European Association for…

Devamı
Honneurs

“Best Reviewer” By the journal “Pharmacoepidemiology…

Devamı
“A Personal Thank You” Letter

By the journal “Pharmacoepidemiology and Drug…

Devamı
“Outstanding Reviewer Recognition”

By the journal “Pharmacoepidemiology and Drug…

Devamı
Bourses

Awarded by the EACPT for the…

Devamı
Publications

PubMed ; http://www.ncbi.nlm.nih.gov/pubmed/?term=Gulmez+SE...

Devamı

BASINDA PROF. GÜLMEZ

Dünya’da Türk Hekimler ve Başarı Öyküleri

Bordeaux Üniversitesi’nde Farmakoepidemiyoloji Alanında Çalışmalarını Sürdüren Dr. Sinem Ezgi Gülmez

DEVAMI

WILEY Press Release

Large but unexplained variations in paracetamol-induced liver failure among European countries: Six-times higher risk in Ireland and a two-fold higher risk in the UK highlighted in study

DEVAMI

Australian Medical Association

“Paracetamol-induced liver failure an English-speaking problem” Kirsty Waterford, Published: 21 JUL 2015
Researchers have identified major differences between European countries in the rate at which people suffer paracetamol-induced acute liver failure, with some at six times the risk of others.

DEVAMI

Läkartidningen. 2015;112:DISX

En jämförelse mellan sju europeiska länder visar stora och oförklarade skillnader i förekomsten av paracetamol-orsakad leverskada som är så allvarlig att den kräver levertransplantation.

DEVAMI